Analysis of RPL37A, MTSS1, and HTRA1 expression as potential markers for pathologic complete response and survival.

CONCLUSION: RPL37A is a potential biomarker for response to NCT and for prognosis. Additional studies evaluating HTRA1 and MTSS1 prognostic value are needed.
PMID: 32951185 [PubMed - as supplied by publisher]

Source: Breast Cancer - September 19, 2020 Category: Cancer & Oncology Authors: Carrara GFA, Evangelista AF, Scapulatempo-Neto C, Abrahão-Machado LF, Morini MA, Kerr LM, Folgueira MAAK, da Costa Vieira RA Tags: Breast Cancer Source Type: research